Literature DB >> 6681537

Antiviral and antitumor compounds from tunicates.

K L Rinehart, J B Gloer, G R Wilson, R G Hughes, L H Li, H E Renis, J P McGovren.   

Abstract

Tunicates provide a rich source of biologically active compounds with potentially useful medicinal properties. The most interesting compounds identified thus far are the didemnins, depsipeptides from a Caribbean Trididemnum species, which are potent inhibitors of L1210 leukemia cells in vitro and are also active in vivo against P388 leukemia and B16 melanoma. In addition the didemnins inhibit growth of a variety of RNA and DNA viruses in vitro and protect mice infected intravaginally with herpes simplex virus type 2. Didemnin B, a derivative of didemnin A, is far more active than A, which argues for the likelihood of further useful chemical modifications in the series.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6681537

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  7 in total

1.  Phase II clinical and pharmacological study of didemnin B in patients with metastatic breast cancer.

Authors:  J A Benvenuto; R A Newman; G S Bignami; T J Raybould; M N Raber; L Esparza; R S Walters
Journal:  Invest New Drugs       Date:  1992-07       Impact factor: 3.850

Review 2.  Didemnin B. The first marine compound entering clinical trials as an antineoplastic agent.

Authors:  H G Chun; B Davies; D Hoth; M Suffness; J Plowman; K Flora; C Grieshaber; B Leyland-Jones
Journal:  Invest New Drugs       Date:  1986       Impact factor: 3.850

3.  Antitumor activity and mechanism of action of the marine compound girodazole.

Authors:  F Lavelle; A Zerial; C Fizames; B Rabault; A Curaudeau
Journal:  Invest New Drugs       Date:  1991-08       Impact factor: 3.850

4.  Phase II study of didemnin B in advanced colorectal cancer.

Authors:  D V Jones; J A Ajani; R Blackburn; K Daugherty; B Levin; Y Z Patt; J L Abbruzzese
Journal:  Invest New Drugs       Date:  1992-08       Impact factor: 3.850

5.  Crystal and molecular structure of didemnin B, an antiviral and cytotoxic depsipeptide.

Authors:  M B Hossain; D van der Helm; J Antel; G M Sheldrick; S K Sanduja; A J Weinheimer
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

Review 6.  Current scenario of peptide-based drugs: the key roles of cationic antitumor and antiviral peptides.

Authors:  Kelly C L Mulder; Loiane A Lima; Vivian J Miranda; Simoni C Dias; Octávio L Franco
Journal:  Front Microbiol       Date:  2013-10-31       Impact factor: 5.640

7.  Chlorinated didemnins from the tunicate Trididemnum solidum.

Authors:  Sridevi Ankisetty; Shabana I Khan; Bharathi Avula; Deborah Gochfeld; Ikhlas A Khan; Marc Slattery
Journal:  Mar Drugs       Date:  2013-11-11       Impact factor: 5.118

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.